GLP-1 Safety
15 articles on GLP-1 Safety, researched and written by the Shotlee Editorial Team from primary sources.
Ozempic & Wegovy Safety: The Yale Study on Online Prescribing
A recent JAMA study reveals significant gaps in medical oversight for online GLP-1 prescriptions. Discover the risks and how to ensure safe access to weight loss medications.
7 min read
Semaglutide and Pregnancy: Understanding New Risks and Weight Rebound
A recent national database study reveals significant obstetric risks associated with semaglutide exposure before and during pregnancy, highlighting the importance of the weight rebound effect.
7 min read
GLP-1 Safety: FDA Action, TrumpRx Access & Weight Loss Drug Risks
Explore the critical safety differences between compounded GLP-1 medications and FDA-approved treatments. Understand the role of new access programs in combating unsafe alternatives.
9 min read
GLP-1 Drugs: Doctors Urge Exercise and Mental Health Too
GLP-1 medications like Ozempic have transformed weight loss for many, but doctors emphasize they're not a standalone solution. Patient Jelon Smart dropped from 285 to 175 pounds only after adding gym workouts to her regimen. Experts stress combining these drugs with movement, smart eating, sleep, and mental health care for long-term success.
5 min read
Dr. Trehan Warns: Generic GLP-1 Drugs Shouldn't Be OTC
As generic GLP-1 drugs flood the Indian market post-patent expiry, Dr. Naresh Trehan warns they shouldn't be available over-the-counter due to serious side effects. Government advisories stress medical supervision to prevent misuse. Experts like Dr. Gupta and Dr. Bhattacharya highlight risks of self-medication with semaglutide and liraglutide.
6 min read
Taking GLP-1s Like Ozempic? Doctors Urge Exercise and Mental Health Focus
Severe ankle pain led Jelon Smart to Ozempic, where she dropped 30 pounds quickly—but plateaued until adding exercise. Doctors like Dafina Allen and Gerald Onuoha stress that GLP-1s alone aren't enough; movement, mental health, and monitored dosing are key for long-term success and safety.
5 min read
Florida Man Charged for Illegally Selling Off-Brand Ozempic
A St. Johns County man, Adam K. Taylor, is now facing federal misdemeanor charges for misbranding and selling off-brand versions of Ozempic (semaglutide) and other GLP-1 drugs without prescriptions. Operating AKT Labs as 'research purposes only,' he instructed undercover officers on weight loss use. This case highlights dangers of unregulated peptides sourced from China.
5 min read
MHRA Urgent Warning: Check Mounjaro 15mg KwikPens for Counterfeits
Health regulators have issued an urgent 'check now' warning to Mounjaro users after counterfeit 15mg KwikPens were dispensed at a Birmingham private clinic. While the fakes contain tirzepatide, unknown manufacturing raises infection risks. Patients are urged to verify their pens immediately.
5 min read
Novo Nordisk Sues Hims & Hers Over Semaglutide Patent
Novo Nordisk has filed a lawsuit against Hims & Hers Health Inc., accusing the telehealth company of breaching its U.S. patent on semaglutide used in blockbuster obesity drugs like Ozempic and Wegovy. Despite Hims scrapping plans for a copycat Wegovy pill, Novo claims the compounded versions remain dangerous and infringing. This legal battle highlights growing tensions over compounded GLP-1 drugs post-shortage.
5 min read
Child Ozempic Overdose: Risks, Symptoms & Prevention Guide
When 7-year-old Jessa injected her mom's Ozempic thinking it was stomach medicine, she faced severe vomiting, dehydration, and kidney risks. This incident underscores the dangers of GLP-1 medications like semaglutide and tirzepatide in children. Discover prevention tips and what to do in an emergency.
4 min read
GLP-1 Pancreatitis Risk: MHRA Warning and Patient Guide
The UK's MHRA has updated guidance on a small but serious risk of acute pancreatitis linked to popular GLP-1 weight-loss drugs like Ozempic, Wegovy, and Mounjaro. With over 1.6 million users, understanding symptoms and reporting is crucial. This guide breaks down the latest data, risks, and management strategies.
4 min read
GLP-1 Overdoses in Kids: Risks, Symptoms & Prevention Guide
Poison control calls for GLP-1 medications have skyrocketed, with children accidentally injecting drugs like Mounjaro leading to severe vomiting and hospitalization. This guide breaks down the risks, what happens in an overdose, and proven prevention strategies. Stay informed to protect your family while benefiting from these powerful weight loss tools.
4 min read
Wegovy Recall: Hair in Syringes, Gold Star Droppings Issue
Novo Nordisk recalled Wegovy pens after FDA inspectors found hair particles in prefilled syringes. Gold Star Distribution issued a broad recall due to rodent feces and droppings in storage. These Class II recalls highlight contamination risks in GLP-1 medications and pharma supply chains.
3 min read
Wegovy Pill in NJ Stores: Where to Get It
The first oral GLP-1 for weight loss, Wegovy pill, is now available in New Jersey stores. One in eight adults have tried GLP-1 meds, with 20% interested per KFF data. Discover where to buy, costs, and safety info.
2 min read
Safety Alert Released for Ozempic and Related GLP-1 Medications
A safety alert has been issued in Australia concerning GLP-1 receptor agonists like Ozempic. The alert highlights a potential connection to suicidal thoughts and a possible reduction in the effectiveness of oral contraceptives.
1 min read